SCD Co., Ltd.

Equities

A042110

KR7042110007

Appliances, Tools & Housewares

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
1,494 KRW -0.07% Intraday chart for SCD Co., Ltd. +0.88% -14.77%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Schroder European Real Estate Investment Trust Refinances EUR9 Million Loan MT
SeaStar Medical Gets Canadian Patent Covering Technology for Cell-Directed Therapy MT
SeaStar Medical's Selective Cytopheretic Device Considered Approvable by the US FDA for Pediatric AKI and Sepsis Treatment MT
Schroder European Real Estate Investment Trust Posts Lower Property Portfolio Valuation as of June 30 MT
Schroder European Real Estate Investment Trust Swings to Fiscal H1 Loss MT
SCD Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
SeaStar Medical Holding Shares Drop After US FDA Rejects Application for Pediatric Selective Cytopheretic Device MT
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group RE
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group RE
Schroder European Real Estate Investment Trust Posts Lower FY22 NAV MT
Schroder European Real Estate Investment Trust Buys EUR11 Million Warehouse in Netherlands MT
China Fines Five Banks 388 Million Yuan Over Irregularities MT
SeaStar Medical Shares Rise 20% After FDA Grants IDE Application DJ
National Bank Begins Coverage on Lycos Energy MT
Graphite Bio Gets Fast Track Designation for GPH101 Sickle Cell Treatment DJ
Editas Medicine Secures FDA Rare Pediatric Disease Designation for EDIT-301 for Beta Thalassemia MT
Global Blood Therapeutics's Oxbryta Gets European Approval for Treatment of Hemolytic Anemia in Patients With SCD MT
Bluebird Bio Shares Drop 20% After Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Program DJ
Global Blood Therapeutics Wins US FDA Nod for Expanded Indication of Oxbryta in Children MT
Global Blood Gets FDA Approval of Supplemental New Drug Application for Oxbryta DJ
Yumanity Therapeutics Parkinson's Disease Drug Candidate Meets Primary Goals; Shares Sink MT
Global Blood Therapeutics Gets FDA Approval for Supplemental NDA DJ
Son Myeong Wan acquired additional 6.5% stake in SCD Co., Ltd. on January 16, 2017. CI
Son Myeong Wan acquired 6.7% stake in SCD Co., Ltd.. CI
Chart SCD Co., Ltd.
More charts
SCD CO., LTD. is a Korea-based company mainly engaged in the manufacture of electronic components for home appliances. The Company produces refrigerator parts, including ice makers, ice shutters, ice selectors, timers, dampers, refrigerant valves and synchronous motors, as well as air conditioner parts including brushless direct current motors and stepping motors. It also involves in the production of units and motors such as stepping motors and brushless direct current (BLDC) motors for microwave ovens, washers, air conditioners, boilers, heat exchangers and others. In addition, the Company engages in the rental business. It distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A042110 Stock
  4. News SCD Co., Ltd.
  5. SeaStar Medical's Selective Cytopheretic Device Considered Approvable by the US FDA for Pediatric AKI and Sepsis Treatment